Young Li
Stock Analyst at Jefferies
(0.58)
# 4,072
Out of 5,058 analysts
7
Total ratings
50%
Success rate
-23.19%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Initiates: Buy | $145 | $133.47 | +8.64% | 1 | Oct 13, 2025 | |
| RXST RxSight | Downgrades: Hold | $24 → $9 | $9.52 | -5.41% | 2 | Jul 10, 2025 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $72.15 | +59.39% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $1.07 | +16.82% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $27.17 | +120.83% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $9.52 | +383.19% | 1 | Jul 16, 2021 |
TransMedics Group
Oct 13, 2025
Initiates: Buy
Price Target: $145
Current: $133.47
Upside: +8.64%
RxSight
Jul 10, 2025
Downgrades: Hold
Price Target: $24 → $9
Current: $9.52
Upside: -5.41%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $72.15
Upside: +59.39%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $1.07
Upside: +16.82%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $27.17
Upside: +120.83%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $9.52
Upside: +383.19%